These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8671408)
1. Ovarian hyperstimulation: effects of GnRH analogues. Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome? Casper RF Hum Reprod; 1996 Jun; 11(6):1144-6. PubMed ID: 8671408 [No Abstract] [Full Text] [Related]
2. Ovarian hyperstimulation: effects of GnRH analogues. Triggering the final stage of ovulation using gonadotrophin-releasing hormone analogues: effective dose, prevention of ovarian hyperstimulation syndrome and the luteal phase. Ben-Arie A; Weissman A; Shoham Z Hum Reprod; 1996 Jun; 11(6):1146-8. PubMed ID: 8671409 [No Abstract] [Full Text] [Related]
3. Ovarian hyperstimulation: effects of GnRH analogues. Ovarian hyperstimulation syndrome after using gonadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications. Kol S; Lewit N; Itskovitz-Eldor J Hum Reprod; 1996 Jun; 11(6):1143-4. PubMed ID: 8671407 [No Abstract] [Full Text] [Related]
4. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553 [TBL] [Abstract][Full Text] [Related]
5. Comparison of gonadotrophin-releasing hormone analogues and human chorionic gonadotrophin for the induction of ovulation and prevention of ovarian hyperstimulation syndrome: a case-control study. Lewit N; Kol S; Manor D; Itskovitz-Eldor J Hum Reprod; 1996 Jul; 11(7):1399-402. PubMed ID: 8671474 [TBL] [Abstract][Full Text] [Related]
6. GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study. Giles J; Requena A; García-Velasco JA; Pacheco A; Pellicer J; Pellicer A Fertil Steril; 2009 Apr; 91(4 Suppl):1366-9. PubMed ID: 18692821 [TBL] [Abstract][Full Text] [Related]
7. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175 [TBL] [Abstract][Full Text] [Related]
8. Use of gonadotrophin-releasing hormone agonists to trigger ovulation. Tay CC Hum Fertil (Camb); 2002 Feb; 5(1):G35-7; discussion G38-9, G41-8. PubMed ID: 11939159 [TBL] [Abstract][Full Text] [Related]
9. Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome. Kasum M; Orešković S; Franulić D; Čehić E; Lila A; Vujić G; Grgić F Acta Clin Croat; 2017 Mar; 56(1):133-142. PubMed ID: 29120551 [TBL] [Abstract][Full Text] [Related]
11. [GnRH agonist triggering in IVF and luteal phase support in women at risk of ovarian hyperstimulation syndrome]. Guivarc'h-Levêque A; Jaffré F; Homer L; Moy L; Priou G; Colleu D; Denis I; Arvis P Gynecol Obstet Fertil; 2013 Sep; 41(9):511-4. PubMed ID: 23972925 [TBL] [Abstract][Full Text] [Related]
12. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone. Weissman A; Barash A; Shapiro H; Casper RF Hum Reprod; 1998 Dec; 13(12):3421-4. PubMed ID: 9886527 [TBL] [Abstract][Full Text] [Related]
13. Ovarian hyper-response to administration of an GnRH-agonist without gonadotropins. Park HT; Bae HS; Kim T; Kim SH J Korean Med Sci; 2011 Oct; 26(10):1394-6. PubMed ID: 22022197 [TBL] [Abstract][Full Text] [Related]
15. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Melo M; Busso CE; Bellver J; Alama P; Garrido N; Meseguer M; Pellicer A; Remohí J Reprod Biomed Online; 2009 Oct; 19(4):486-92. PubMed ID: 19909588 [TBL] [Abstract][Full Text] [Related]
16. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol. Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development. Krause BT; Ohlinger R Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065 [TBL] [Abstract][Full Text] [Related]
19. [How to prevent completely ovarian hyperstimulation with GnRH-based stimulation protocols]. Kol S Akush Ginekol (Sofiia); 2001; 40(4):36-41. PubMed ID: 11803870 [No Abstract] [Full Text] [Related]
20. Use of GnRH analog for induction of the ovulatory surge of gonadotropins in patients at risk of the ovarian hyperstimulation syndrome. Kulikowski M; Wołczyński S; Kuczyński W; Grochowski D; Szamatowicz M Gynecol Endocrinol; 1995 Jun; 9(2):97-102. PubMed ID: 7502696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]